News and Press Releases
Sustainability vs Suitability: Challenging Conventional Thinking in Temperature-Controlled Packaging Design
ISTA European Packaging Symposium, Frankfurt 8-9 October 2024 Maarten Kleverlaan to address sustainability in packaging at International Safe Transit Association Symposium Innovative approaches to temperature-controlled packaging design Emphasising financial and...
Category: Manufacturing and Packing
Posted: September 4, 2024
The countdown is on as the PPMA Show prepares to open its doors
The start of the highly anticipated 2024 PPMA Show is nearly here. The show will take place once again at the NEC Birmingham from 24 to 26 September. The UK’s...
Category: Pharmaceutical
Posted: September 3, 2024
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress
In the Overall Population, Achieved 28% Reduction in Primary Composite of All-Cause Mortality and Recurrent Cardiovascular Events, and 31% and 36% Reductions in All-Cause Mortality During the 33-36-Month Double-Blind Period...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: August 30, 2024
DRUG DISCOVERY 2024: CONNECTING MINDS, TRANSFORMING SCIENCE, EMPOWERING COMMUNITY
We are proud to be media partners of ELRIG's Drug Discovery 2024! Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic...
Category: Drug Discovery
Posted: August 29, 2024
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK
Introducing Endotoxin Testing with PYROSTAR™ Neo+
A wildlife-conscious recombinant alternative to the conventional LAL assay 28 August 2024 -- Eastleigh, England -- In line with its sustainability ethics, Alpha Laboratories is delighted to introduce the new...
Category: Biotechnology, Other, Pharmaceutical
Posted: August 28, 2024
Alpha Laboratories Ltd., 40 Parham Drive, Eastleigh, SO50 4NU, Hampshire, UK
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III
26 August, 2024 – New Jersey, US – Merck, known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved WINREVAIR™ (sotatercept), in...
Category: Pharmaceutical
Posted: August 28, 2024
1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France
European Commission Approves Astellas’ PADCEVTM (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer
First regimen approved in advanced urothelial cancer to demonstrate superiority to platinum-containing chemotherapy, the standard of care for nearly 40 years European Marketing Authorization based on positive overall survival and...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: August 28, 2024
CPHI Korea 2024 opens with 15% growth as innovation booms in Korea
Event’s most international edition sees health ingredients, nutraceuticals and biopharma driving growth 27 August 2024 – Korea – CPHI Korea – at the heart of Korea’s pharmaceutical industry – opens...
Category: Pharmaceutical
Posted: August 28, 2024
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
PCI is the first CDMO to undergo ICMRA’s inspection pilot program. 21 August 2024 - Philadelphia, US – PCI Pharma Services (PCI), a leading global contract development and manufacturing organization...
Category: Manufacturing and Packing
Posted: August 27, 2024
Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
23 August 2024 –Lund, Sweden – Hansa Biopharma AB, (“Hansa” or the “Company”) (Nasdaq Stockholm: HNSA), today announced that Matthew Shaulis, Chief Commercial Officer and US President has decided to...
Category:
Posted: August 27, 2024
European Commission approves RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer after failure of prior therapy
Patients with EGFR ex19del or EGFR L858R mutations, the most common EGFR mutations in NSCLC, have until now faced a poor prognosis and limited treatment options after disease progression on...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: August 27, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Stockholm3 independently validated at the world-renowned Martini Klinik
23 August 2024 – Stockholm, Sweden – Stockholm3 has been independently, externally validated at the Martini Klinik, the world-renowned prostate cancer center in Hamburg, Germany. The Martini validation study demonstrated...
Category: Clinical Trials
Posted: August 27, 2024
European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial carcinoma and susceptible FGFR3 alterations Approval based on THOR results,...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: August 23, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval 22 August 2024 -- Massachusetts, US -- Moderna, Inc today...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 22, 2024
Data Supporting FDA Approval Published in High-Impact Journal
Publication of results from ANGLE’s Parsortix PC1 system validates use of Parsortix System for CTC isolation and harvest in metastatic breast cancer 22 August 2024 -- Guilford, UK -- ANGLE...
Category: Biotechnology, Other, Pharmaceutical
Posted: August 22, 2024
